Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Alobresib (GS-5829) CAS：1637771-14-2
Alobresib (GS-5829)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-2257 | 50mg | 425.00 | + Add to cart |
|
| R-C-2257 | 100mg | 720.00 | + Add to cart |
|
| R-C-2257 | 200mg | 1150.00 | + Add to cart |
|
|
|
||||
Product description
Alobresib(GS-5829)is a novel BET inhibitor that represents a highly effective therapeutics agent against recurrent/chemotherapy-resistant USC-overexpressing c-Myc.Alobresib(GS-5829)inhibits CLL cell proliferation and induces leukemia cell apoptosis through deregulation of key signaling pathways,such as BLK,AKT,ERK1/2,and MYC.Alobresib (GS-5829)also inhibits NF-κB signaling.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 2 years |
Document
msds---Alobresib (GS-5829) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
